Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to determine if nutritional therapy can effectively treat/prevent T2DM and its consequent cardiomyopathy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01373814
Study type Observational
Source Washington University School of Medicine
Contact
Status Completed
Phase
Start date September 3, 2010
Completion date June 17, 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05469659 - Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Phase 2
Completed NCT05376930 - Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. Phase 3
Recruiting NCT04682795 - Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM N/A
Recruiting NCT06350890 - Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Phase 3
Completed NCT04634500 - The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. Phase 3
Recruiting NCT03789695 - RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD Phase 4
Completed NCT04632862 - The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. Phase 3
Completed NCT04688359 - Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM N/A
Completed NCT05983289 - Single Escalating Dose Study Of HSK7653 In Healthy Subjects Phase 1
Recruiting NCT04272359 - Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
Completed NCT03467932 - A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus Phase 2
Completed NCT05376969 - Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin Phase 3
Recruiting NCT06415773 - Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Phase 3
Recruiting NCT06094491 - Virtual Diabetes Group Visits Across Health Systems Phase 2
Completed NCT05279911 - Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion N/A
Active, not recruiting NCT03257449 - Effect of Viscous Soluble Fibres on Body Weight N/A
Terminated NCT04754334 - A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Phase 3
Not yet recruiting NCT06293417 - To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Not yet recruiting NCT03658031 - Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction Phase 3
Terminated NCT03067480 - Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients N/A